Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Clinical and Vaccine Immunology : CVI|May 17, 2013
Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in ChinaHaiBo Wang, Hui Cui, ZhenGrong Ding, et al.
Lancet (London, England)|June 11, 2013
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010Gonghuan Yang, Yu Wang, Yixin Zeng, et al.
Human Vaccines & Immunotherapeutics|September 21, 2016
Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adultsHuai Wang, Binyu Cai, Delong Rao, et al.
Expert Review of Vaccines|December 6, 2023
Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analysesJiamin Qiu, Shiwen Zhang, Yonghui Feng, et al.
Expert Review of Vaccines|September 10, 2021
Immunogenicity, safety, and compliance of high- and standard-strength four-dose hepatitis B vaccination regimens in patients receiving methadone maintenance therapy in China: a randomized, parallel-arm controlled trialYongliang Feng, Tian Yao, Yizhuo Gao, et al.
Emerging Infectious Diseases|April 19, 2017
Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, ChinaFuqiang Cui, Lipin Shen, Li Li, et al.
Expert Review of Vaccines|August 15, 2022
Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in ChinaYujie Han, Na Cao, Xiaoxiao Lu, et al.
Preventive Medicine|August 5, 2014
Multilevel evaluation of 'China Healthy Lifestyles for All', a nationwide initiative to promote lower intakes of salt and edible oilJuan Zhang, Thomas Astell-Burt, Dong-Chul Seo, et al.
Hepatology (Baltimore, Md.)|June 28, 2020
Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting SystemFuzhen Wang, Xiaojin Sun, Feng Wang, et al.
The Journal of Infectious Diseases|November 6, 2010
Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmissionYong Zhang, Dongmei Yan, Shuangli Zhu, et al.
Pageof 18